IGF1 and IGFBP3 in acute respiratory distress syndrome

European Journal of Endocrinology

Volumn 166, Issue 1, 2012, Pages 121-129

  Ahasic, Amy M ^a,b   Zhai, Rihong ^b   Su, Li ^b   Zhao, Yang ^b   Aronis, Konstantinos N ^c   Thompson, B Taylor ^d   Mantzoros, Christos S ^b,c   Christiani, David C ^b,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; APACHE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CASE STUDY; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SURVIVOR;

ADULT; AGED; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS;

EID: 84055190055     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0778     Document Type: Article

References (31)

1. Clemmons DR. Involvement of insulin-like growth factor-I in the control of glucose homeostasis. Current Opinion in Pharmacology 2006 6 620-625. (doi:10.1016/j.coph.2006.08.006)
2. Krein PM &Winston BW. Roles for insulin-like growth factor 1 and transforming growth factor-b in fibrotic lung disease. Chest 2002 122 289S-293S. (doi:10.1378/chest.122.6-suppl.289S)
3. Allen JT, Bloor CA, Knight RA & Spiteri MA. Expression of insulin-like growth factor binding proteins in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. American Journal of Respiratory Cell and Molecular Biology 1998 19 250-258. (Pubitemid 128354188)
4. Aston C, Jagirdar J, Lee TC, Hur T, Hintz RL & Rom WN. Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 1995 151 1597-1603.
5. Pala L, Giannini S, Rosi E, Cresci B, Scano G, Mohan S, Duranti R &Rotella CM. Direct measurement of IGF-1 and IGFBP-3 in bronchoalveolar lavage fluid from idiopathic pulmonary fibrosis. Journal of Endocrinological Investigation 2001 24 856-864. (Pubitemid 34036715)
6. Pilewski JM, Liu L, Henry AC, Knauer AV & Feghali-Bostwick CA. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. American Journal of Pathology 2005 166 399-407. (doi:10.1016/S0002-9440(10) 62263-8)
7. Glaser S, Friedrich N, Ewert R, Schaper C, Nauck M, Dorr M, Volzke H, Felix SB, Krebs A, Wallaschofski H & Koch B. Association between serum insulin-like growth factor (IGF) 1 and IGF binding protein-3 and lung function. Journal of Clinical Endocrinology and Metabolism 2009 94 2452-2458. (doi:10.1210/jc.2008-2662)
8. Kaklamani VG, Linos A, Kaklamani E, Markaki I & Mantzoros CS. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. Journal of Clinical Oncology 1999 17 813-817. (Pubitemid 29109310)
9. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Koumantaki Y &Mantzoros CS. Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. Journal of Clinical Oncology 1999 17 3291-3298. (Pubitemid 29470665)
10. Capoluongo E, Ameglio F & Zuppi C. Insulin-like growth factor-1 and complications of prematurity: a focus on bronchopulmonary dysplasia. Clinical Chemistry and Laboratory Medicine 2008 46 1061-1066. (doi:10.1515/CCLM.2008.211)
11. Mesotten D & Van den Berghe G. Changes within the GH/IGF-1/IGFBP axis in critical illness. Critical Care Clinics 2006 22 17-28. (doi:10.1016/j.ccc. 2005.09.002)
12. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G & Hinds CJ. Increased mortality associated with growth hormone treatment in critically ill adults. New England Journal of Medicine 1999 341 785-792. (doi:10.1056/NEJM199909093411102)
13. Schnapp LM, Donohoe S, Chen J, Sunde DA, Kelly PM, Ruzinski J, Martin T & Goodlett DR. Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. American Journal of Pathology 2006 169 86-95. (doi:10.2353/ajpath.2006.050612)
14. Krein PM, Sabatini JB, Tinmouth W, Green FHY & Winston BW. Localization of insulin-like growth factor-I in lung tissues of patients with fibroproliferative acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 2003 167 83-90. (doi:10.1164/rccm. 2201012)
15. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD &Christiani DC. Clinical predictors of mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Critical Care Medicine 2005 33 1191-1198. (doi:10.1097/01.CCM.0000165566.82925.14)
16. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A & Spragg R. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine 1994 149 818-824. (Pubitemid 24082248)
17. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A &Harrell FE. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991 100 1619-1636. (doi:10.1378/chest.100.6.1619)
18. Lam CS, Chen MH, Lacey SM, Yang Q, Sullivan LM, Xanthakis V, Safa R, Smith HM, Peng X, Sawyer DB & Vasan RS. Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 1479-1484. (doi:10.1161/ATVBAHA.110.203943)
19. Verghese GM, McCormick-Shannon K, Mason RJ & Matthay MA. Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. American Journal of Respiratory and Critical Care Medicine 1998 158 386-394. (Pubitemid 28378163)
20. Marshall RP, Bellingan G, Webb S, Puddicombe A, Goldsack N, McAnulty RJ & Laurent GJ. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. American Journal of Respiratory and Critical Care Medicine 2000 162 1783-1788.
21. Chestnutt AN, Matthay MA, Tibayan FA & Clark JG. Early detection of type III procollagen peptide in acute lung injury. American Journal of Respiratory and Critical Care Medicine 1997 156 840-845.
22. Ricou B, Nicod L, Lacraz S, Welgus HG, Suter PM & Dayer JM. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 1996 154 346-352. (Pubitemid 26269102)
23. Lebl J, Zahradnikova M, Bartosova J, Zemkova D, Pechova M &Vavrova V. Insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in cystic fibrosis: a positive effect of antibiotic therapy and hyperalimentation. Acta Paediatrica 2001 20 868-872. (doi:10.1111/j.1651-2227. 2001.tb02447.x)
24. Pape GS, Friedman M, Underwood LE & Clemmons DR. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest 1991 99 1495-1500. (doi:10.1378/chest.99.6.1495)
25. Kythreotis P, Kokkini A, Avgeropoulou S, Hadjioannou A, Anastasakou E, Rasidakis A & Bakakos P. Plasma leptin and insulin-like growth factor 1 levels during acute exacerbations of chronic obstructive pulmonary disease. BMC Pulmonary Medicine 2009 9 11. (doi:10.1186/1471-2466-9-11)
26. Lin MC, Leung SY, Fang WF, Chin CH & Chung KF. Downregulation of insulin-like growth factor I (IGF-I) in the mouse diaphragm during sepsis. Chang Gung Medical Journal 2010 33 501-508.
27. Sassoon CSH, Zhu E, Fang L, Ramar K, Jiao GY & Caiozzo VJ. Interactive effects of corticosteroid and mechanical ventilation on diaphragm muscle function. Muscle and Nerve 2011 43 103-111. (doi:10.1002/mus.21821)
28. Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, Bouillon R & Decramer M. Muscle force during an acute exacerbation if hospitalized patients with COPD and its relationship to CXCL8 and IGF-1. Thorax 2003 58 752-756. (doi:10.1136/thorax.58.9.752)
29. Crul T, Spruit MA, Gayan-Ramirez G, Quarck R, Gosselink R, Troosters T, Pitta F & Decramer M. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. European Journal of Clinical Investigation 2007 37 897-904. (doi:10.1111/j.1365-2362.2007.01867.x)
30. Schuetz P, Müller B, Nusbaumer C, Wieland M & Christ-Crain M. Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients. European Journal of Endocrinology 2009 160 157-163. (doi:10.1530/EJE-08-0786)
31. Iioka Y, Tatsumi K, Sugito K, Moriya T & Kuriyama T. Effects of insulin-like growth factor on nitrogen balance during hypoxic exposure. European Respiratory Journal 2002 20 293-299. (doi:10.1183/09031936.02.00234302)